Luxturna®
Company
Spark Therapeutics
Use
Treatment of inherited vision loss due to specific gene mutations.
Features
Gene therapy targeting specific gene mutations.
NIH Contribution
Gene therapy research to enable scalable and efficient AAV purification.
HHS Institute/Agency
NIDCR
Inventor(s)
Kaludov, N. et al.
Year
2017
